Sensex, Nifty snap longest losing streak seen in last four years
Advertisement

Sensex, Nifty snap longest losing streak seen in last four years

By Reuters

  • 01 Mar 2023
Sensex, Nifty snap longest losing streak seen in last four years
Credit: Reuters

Shares snapped an eight-day losing streak on Wednesday, boosted by metal stocks on strong manufacturing activity data from top consumer China.

The Nifty 50 index rose 0.85% to 17,450.90, while the S&P BSE Sensex closed 0.76% higher to 59,411.08.

All the 13 major sectoral indexes advanced, with high weightage financials and information technology stocks adding 0.62% and 1.46%, respectively.

Advertisement

Metal index jumped nearly 4% and was the top sectoral gainer, with 14 of the 15 constituents logging gains.

Data on Wednesday showed manufacturing activity in China expanded at the fastest pace in more than a decade in February, as production zoomed after COVID-19 restrictions were lifted late last year.

"The surge in China's manufacturing PMI indicates a rise in domestic consumption of commodities in the country, and is a major positive for the sector," Pallav Agarwal and Suman Kumar, analysts at Antique Stock Broking, wrote in a note.

Advertisement

Asian markets also advanced, with the MSCI's broadest index of Asia-Pacific shares outside Japan rising nearly 2%. [MKTS/GLOB]

The rise in Nifty 50 on Wednesday comes after a 4.1% fall in the index over the last eight sessions amid persistent rate hike fears and sustained foreign selling.

Analysts cautioned that Wednesday's moves were likely temporary.

Advertisement

"An intermittent rally can certainly happen after the recent correction in the markets," said Anita Gandhi, director at Arihant Capital Markets, adding that for the gains to sustain, "clear triggers are needed".

Forty-five of the Nifty 50 constituents logged gains. Adani Enterprises and Hindalco were among the top Nifty 50 gainers.

Among individual stocks, Axis Bank advanced 2.49% after the lender completed the deal to buy Citi's India consumer business.

Advertisement

On the flip side, Cipla fell 0.72% on fears of a potential delay in the launch of asthma drug due to recent U.S. drug regulator's observations on its Madhya Pradesh plant.

Share article on

Advertisement
Advertisement